You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oligometastatic recurrent hormone sensitive prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Node; Prostate, Bone Metastases, Prostate Cancer Patients Trial in France (SBRT + Durvalumab, SBRT)

Recruiting
  • Node; Prostate
  • +2 more
  • SBRT + Durvalumab
  • SBRT
  • Bordeaux, France
  • +9 more
Sep 14, 2021

Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

Not yet recruiting
  • Oligometastatic Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

Not yet recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Oct 3, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Learn More About How Safe Darolutamide is Under Real-world

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
  • No Intervention
  • Multiple Locations, Japan
    Many Locations
Aug 24, 2023

Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

Recruiting
  • Prostate Cancer Metastatic
  • +2 more
  • stereotactic body radiotherapy
  • +2 more
  • Umeå, Umea, Sweden
  • +1 more
May 19, 2022

Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Aug 2, 2023

Apalutamide in Metastatic Hormone Sensitive Prostate Cancer

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Cardiff, United Kingdom
    • +4 more
    Aug 25, 2023

    Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

    Active, not recruiting
    • Metastatic Prostate Adenocarcinoma
    • +6 more
    • Intensity-Modulated Radiation Therapy
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

    Recruiting
    • Prostate Adenocarcinoma
    • Leuprolide Acetate
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

    Recruiting
    • Prostate Cancer Metastatic
    • Ablative Radiation Therapy
    • Standard of care
    • Victoria, British Columbia, Canada
    • +14 more
    Nov 14, 2022

    Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)

    Not yet recruiting
    • Oligometastatic Prostate Carcinoma
    • ADT combined with abiraterone
    • neoadjuvant hormone and RT
    • Hefei, Anhui, China
    • +5 more
    Jan 28, 2023

    Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

    Active, not recruiting
    • Prostatic Neoplasms
    • San Francisco, California
      University of California San Francisco
    Sep 20, 2022

    Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,

    Recruiting
    • Prostate Cancer
    • +2 more
    • Moderate hypo-fractionation
    • Ultra-hypo-fractionation
    • Umeå, Sweden
      Cancercenter University hospital of Umeå
    Nov 1, 2022

    Prostate Cancer Trial in New York (177Lu-PSMA-617, Stereotactic Body Radiotherapy (SBRT))

    Active, not recruiting
    • Prostate Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Nov 17, 2022

    High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate

    Not yet recruiting
    • High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
    • dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
    • placebo; abiraterone acetate tablets; prednisone tablets
    • (no location specified)
    Oct 20, 2023

    Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

    Active, not recruiting
    • Metastatic Castration Sensitive Prostate Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 4, 2022

    Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

    Not yet recruiting
    • Prostate Cancer
    • Chicago, Illinois
      Northwestern University
    Sep 27, 2023

    Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed

    Recruiting
    • Prostate Cancer
    • +4 more
    • Aalst, Belgium
    • +6 more
    Jan 25, 2023

    Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

    Recruiting
    • Hormone Sensitive Metastatic Prostate Cancer
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Jul 13, 2022

    Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

    Recruiting
    • Metastatic Hormone Refractory Prostate Cancer
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 6, 2022

    Based Discrete Choice Experiment Study in Prostate Cancer Study

    Completed
    • Prostate Cancer
    • Metastatic Hormone-sensitive Prostate Cancer
      • Durham, North Carolina
        Duke Clinical Research Institute
      Jan 10, 2023

      Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)

      Not yet recruiting
      • Prostate Cancer
      • 177Lu-DOTA-TLX591
      • St Leonards, New South Wales, Australia
      • +1 more
      Jul 18, 2022